20 May 2022 | NewsKaren Orr Nurse Education Scholarship – 2022 applications now openRead the full article
In Australia and globally we continue to face new challenges in the prevention of COVID-19. This webinar, held on Thursday 26 August 2021, discussed what’s next for Australia’s COVID-19 vaccine program as we aim to emerge from the pandemic.
Watch the recording of this webinar to:
Dr Randall Hyer
Senior Vice President, Moderna Therapeutics, Inc
Dr Randall Hyer has over three decades of experience in medicine and public health in both the public and private sectors. After graduating with distinction from the US Naval Academy, he studied at Duke Medical School and then earned the PhD in molecular biology from Oxford University. He then spent 13 months on the “ice” in Antarctica as the Station Physician for the winter. Dr Hyer then shifted to public health and vaccines, serving four years at the World Health Organization as a medical officer responding to outbreaks and emergencies, including anthrax, Ebola, SARS, avian influenza, as well as tsunamis and earthquakes.
In response to the need for effective communication, Randy co-authored a popular WHO handbook on risk and crisis communication during public health emergencies. In industry, Randy’s experience covers vaccines, biologics, biosimilars and small molecule development. He was pivotal to the 2017 approval of a two-dose adult hepatitis B vaccine (HEPLISAV-B), the first FDA-approved vaccine with a truly novel adjuvant.
Beyond development, his responsibilities have included directing vaccine and pharmaceutical safety programs, overseeing vaccine clinical operations and biometrics functions, engaging medical scientists and policy-makers, and managing crises. Randy’s perspectives and contributions span his residing in eight and travelling to 100 plus countries in diverse roles across the public and private sectors.
Professor Jodie McVernon
Director of Epidemiology, Peter Doherty Institute for Infection and Immunity
Professor Jodie McVernon is a public health physician and epidemiologist. She has extensive expertise in clinical vaccine trials, epidemiological studies and mathematical modelling of infectious diseases, gained in Oxford, London and Melbourne.
For the past 15 years, she has been building capacity in infectious diseases modelling in Australia to inform immunisation and pandemic preparedness policy. She has led nationally distributed networks of modellers informing responses to the 2009 H1N1 influenza pandemic and the current COVID-19 pandemic.
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2022 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS